These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38589859)

  • 1. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
    Jiang J; Lu Y; Chu J; Zhang X; Xu C; Liu S; Wan Z; Wang J; Zhang L; Liu K; Liu Z; Yang A; Ren X; Zhang R
    J Nanobiotechnology; 2024 Apr; 22(1):159. PubMed ID: 38589859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer.
    Li Z; Yang L; Wang H; Binzel DW; Williams TM; Guo P
    Nucleic Acid Ther; 2021 Oct; 31(5):364-374. PubMed ID: 33999716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo.
    Zhou Z; Wu X; Zhan R; Li X; Cheng D; Chen L; Wang T; Yu H; Zhang G; Tang X
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36224722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
    Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
    Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
    Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer.
    Rao DY; Huang DF; Si MY; Lu H; Tang ZX; Zhang ZX
    Front Immunol; 2023; 14():1142539. PubMed ID: 37122754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer.
    Nie H; Xie X; Zhang D; Zhou Y; Li B; Li F; Li F; Cheng Y; Mei H; Meng H; Jia L
    Nanoscale; 2020 Jan; 12(2):877-887. PubMed ID: 31833519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.
    Li X; Wang Y; Wang J; Zhang T; Zheng L; Yang Z; Xing L; Yu J
    Int J Cancer; 2018 Jul; 143(1):212-224. PubMed ID: 29430654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.
    Saruwatari K; Ikeda T; Saeki S; Shingu N; Imamura K; Komatu T; Ushijima S; Maruyama H; Kashiwabara K; Tomita Y; Ichiyasu H; Fujii K; Sakagami T
    Anticancer Res; 2019 Feb; 39(2):923-931. PubMed ID: 30711977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p/EPB41L5 axis to promote non-small cell lung cancer brain metastasis.
    Wu D; Deng S; Li L; Liu T; Zhang T; Li J; Yu Y; Xu Y
    Cell Death Dis; 2021 Jul; 12(8):721. PubMed ID: 34285192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.
    Garbuzenko OB; Kuzmov A; Taratula O; Pine SR; Minko T
    Theranostics; 2019; 9(26):8362-8376. PubMed ID: 31754402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG
    Man RCH; Qiu Y; Leung SWS; Fruhwirth GO; Lam JKW
    Eur J Pharm Biopharm; 2024 Feb; 195():114177. PubMed ID: 38185193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
    Zhu Y; Liu C; Xu Z; Zou Z; Xie T; Xing P; Wang L; Li J
    Chin Med J (Engl); 2023 Nov; 136(21):2551-2561. PubMed ID: 37160733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth.
    Lu Y; Wang Y; Zhang M; Liu L; Li F; Zhang J; Ye M; Zhao H; Zhao J; Yan B; Yang A; Zhang R; Li X; Ren X
    Oncotarget; 2016 Apr; 7(17):23594-607. PubMed ID: 26988752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR
    Yin W; Zhao Y; Kang X; Zhao P; Fu X; Mo X; Wang Y; Huang Y
    Theranostics; 2020; 10(14):6122-6135. PubMed ID: 32483443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer.
    Guo Y; Xue W; Sun S; Chen X; Li H; Yan C
    Clin Exp Med; 2022 Nov; 22(4):647-659. PubMed ID: 35089454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer.
    Wu S; Luo M; To KKW; Zhang J; Su C; Zhang H; An S; Wang F; Chen D; Fu L
    Mol Cancer; 2021 Jan; 20(1):17. PubMed ID: 33461557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.